Introduction
Interferons (IFNs) are a family of secreted cytokines with antiviral, antiproliferative and immunomodulatory activities (Pestka et al., 1987; Romeo et al., 1989; Sen and Ransoho, 1993) . IFNs a and b (type I) are produced by many types of cells in response to viral infection, double stranded RNA treatment or other stimuli (Chelbi-Alix et al., 1994 and references within) . IFNg (type II) is induced in T-lymphocytes and natural killer cells in response to antigens or mitogens. These IFNs, after interacting with dierent speci®c highanity receptors on the plasma membrane, activate dierent cascades of signal transduction reactions leading to the transcriptional activation of IFNstimulated genes (ISGs) (Schindler, 1995) . IFNinduced signal transduction is mediated by the phosphorylation-activation of the signal transducers and activators of transcription (STAT) proteins (Schindler, 1995) . In response to IFNa/b, Jak1 and Tyk2, phosphorylate Stat1, Stat2 and Stat3. The IFNstimulated gene factor 3 (ISGF3) is formed between Stat1 and Stat2 (Stat1 : 2) in association with the DNAbinding protein, p48, a member of the interferon regulatory factor (IRF) family Schindler et al., 1992) . This complex binds to the IFN-stimulated response element (ISRE) found in promoters of IFNa/b-stimulated genes. In addition, homo-and heterodimers of Stat1 and Stat3 (Stat1 : 1, Stat3 : 3 and Stat1 : 3) bind to a palindromic version of the IFNg-activated site (GAS), regulating the expression of distinct ISGs (Kanno et al., 1993; Khan et al., 1993; Pine et al., 1994) . In response to IFNg, Jak1 and Jak2, phosphorylate Stat1 which forms a homodimer and binds to the GAS motif.
The diverse biological eects of IFNs are believed to be mediated by a speci®c set of more than 40 proteins directly involved in response to IFN treatment. However, only a few of these proteins, namely the p68 kinase (PKR) (Koromilas et al., 1992; Meurs et al., 1992 Meurs et al., , 1993 , the 2'5' oligoadenylate (2'5'A) synthetase (Chebath et al., 1987) , certain forms of Mx proteins (Staeheli et al., 1993) and the promyelocytic leukemia (PML) protein (Mu et al., 1994; Chelbi-Alix et al., 1995 Koken et al., 1995; Liu et al., 1995; Stadler et al., 1995) are implicated in the antiviral state and/or anti-tumor and anti-growth activities of IFNs. The enzymatic properties of PKR and 2'5'A synthetase have been well characterized (reviewed in Sen and Ransoho, 1993) . In short, PKR, once phosphorylated, acquires the capacity to phosphorylate the a subunit of the translation initiation factor eIF-2, leading to the inhibition of protein synthesis. The 2'5'A synthetase catalyses the synthesis, from ATP, of unusual 2'5' oligoadenylates, which in turn activate a latent ribonuclease. The mechanism of action of Mx or PML proteins remains to be elucidated. PML is a nuclear matrix protein with growth suppressing properties, whose expression is deregulated during oncogenesis (Mu et al., 1994; Koken et al., 1995; Liu et al., 1995) . PML is associated to nuclear compartments called nuclear bodies where it colocalizes with two IFN-induced proteins, Sp100 (an autoantigen detected in primary biliary cirrhosis, Guldner et al., 1992) , and NDP52 (Korioth et al., 1995) .
Retinoic acid (RA) is structurally related to vitamin A. RA exerts dierent eects such as inhibition of proliferation, induction of dierentiation and immunomodulation. RA modi®es gene expression by binding to speci®c nuclear receptors (Mangelsdorf et al., 1994) . Both RA and IFNs exert antiproliferative eects on various cell types (Frey et al., 1991) . Several groups have reported a higher inhibition of cell proliferation by a combination of RA with IFN, compared to treatment by each agent alone (Lancillotti et al., 1995 and references within) . However, the mechanism of this collaborative eect is not yet fully elucidated. It is also not known whether these events are accompanied by an enhancement of the IFN-induced antiviral state. It has been recently shown that RA upregulates IRF-1 gene expression in myeloid cells (Matikainen et al., 1996; Gianni' et al., 1997) and that RA also increases the level of Stat1 in MCF-7, a breast tumor cell line resistant to growth inhibition by IFNb (Kolla et al., 1996) .
In this report, we analysed the eect of RA, alone and in combination with IFNa, on the expression of 2'5'A synthetase, PKR, Sp100 and PML in dierent human cell lines. The capacity to inhibit cell proliferation and vesicular stomatitis virus (VSV) , 100 mg/ml of poly(I)-poly(C) (^) or IFNa (500 units/ml) (*). At the indicated times, 2'5'A synthetase activity was determined in cell extracts as described in Materials and methods. Values are an average of three experiments. (b) Increase of PML and Sp100 proteins by RA. HL-60 cells were treated by RA (10 76 M) for 3 days. Immuno¯uorescence was revealed by monoclonal anti-PML antibodies followed by Texas red, and polyclonal anti-Sp100 antibodies were visualized with FITC replication was also tested. We demonstrate that the eects of RA could be mediated through multiple mechanisms involving increase of STAT expression, IFN-induced STAT activation, direct IRF-1 gene induction and IFNa secretion.
Results
Increase of 2'5'A synthetase, PML and Sp100 proteins expression by RA The 2'5'A synthetase activity induced by 10 76 M RA was studied in HL-60 cells and compared with that induced by 100 mg/ml of poly(I)-poly(C), a commonly used IFN inducer. The basal level of 2'5'A synthetase activity remained constant in HL-60 cells for periods from 1 ± 7 days, whereas it increased in the presence of RA. The kinetics of enzyme activity for RA ( Figure 1a) shows a sixfold enhancement at day 1, reaching a maximum at day 3 (50-fold), and a subsequent decline of 80% at day 7. The maximal induction with poly(I)-poly(C) was only fourfold after 3 days. Thus, clearly RA, compared to poly(I)-poly(C), is a better inducer of 2'5'A synthetase activity in HL-60 cells. Note that, compared to IFN, RA induced enzyme activity with slower kinetics. In WISH cells, the maximum increase of RA-induced 2'5'A synthetase activity occurred at 24 h at a concentration of 10 75 M (Bourgeade and Besancon, 1984 and Table 1 ). These results, considered in the light of the recent observations that three nuclear bodies-associated proteins, PML, Sp100 and NDP52 are IFN-induced (Guldner et al., 1992; ChelbiAlix et al., 1995; Korioth et al., 1995; Stadler et al., 1995) , prompted us to ask whether the 2'5'A synthetase inducing action of RA could be generalized to other IFN-inducible proteins, such as PML and Sp100. Both of these proteins localize to discrete speckles within the nucleus and their expression can be monitored with a high degree of sensitivity by immuno¯uorescence (Koken et al., 1994) . Figure 1b shows that a 3 day treatment of HL-60 cells with RA enhanced the levels of PML and Sp100 as revealed by an increased immuno¯uorescence staining. Western blot analysis of extracts from these cells indicated that Sp100, PML and PKR (data not shown) are increased upon RA treatment with kinetics similar to that of 2'5'A synthetase activity.
Eect of the combination of RA and IFNa on IFNinducible gene products
To evaluate the molecular basis of the previously described antiproliferative eect caused by the combination of RA and IFNa in dierent cell lines (Frey et al., 1991; Lancillotti et al., 1995) , we ®rst analysed the expression of 2'5'A synthetase, PKR, PML and Sp100, using HL-60, WISH or HeLa cells. Cells were treated for 24 h with 10 76 M RA for HL-60 or 10 75 M for WISH and HeLa, in the presence or absence of 100 units/ml of IFNa. As shown in Table 1 , 2'5'A synthetase activity was increased by RA or IFNa in both HL-60 and WISH cells. However, when RA was combined with IFNa, 2'5'A synthetase expression was even more enhanced. The enzyme activities were 1.6-and 2.3-fold higher respectively in WISH and HL-60 cells treated with RA plus IFNa vs IFNa alone. In HeLa cells, we failed to detect an increase of 2'5'A synthetase activity by RA alone or RA-IFNa compared to IFNa alone (Table 1) .
We then investigated the eects of RA and IFN on PML, Sp100 and PKR proteins expression. Equal amounts of total protein extracts from control and treated HL-60 cells for 24 h were analysed by Western blotting. At that time, RA per se had no eect and IFNa at 100 units/ml only slightly increased the 76 M RA, IFNa (100 units/ml) or their combination for 24 h. 20 mg of extracts were analysed by Western blot and revealed by rabbit anti-PML, anti-Sp100, anti-actin and mouse anti-PKR antibodies. Note that all bands visualized by anti-PML or anti-Sp100 antibodies are likely to isoforms derived from alternative splicing of unique gene. Molecular size markers are indicated on the left expression of these proteins. However, when RA was combined with IFN, an enhancement in the expression of PML, Sp100 and PKR was observed ( Figure 2 ). Note that, as previously described , dierent forms of PML and of Sp100 are induced by IFNs. They are derived from alternative RNA splicing of a single PML or Sp100 gene. A similar enhanced level of expression of these proteins with combined treatment was observed in WISH cells, but, again, not in HeLa cells (data not shown). Treatment of HL-60 cells with 1000 units/ml of IFNa leads to a much higher increase in the level of PML, Sp100 and PKR proteins and the combination with RA does not give a measurable enhancement of their expression (data not shown). Taken together, these data suggest that RA and IFNa act through similar intracellular pathways. Table 3 ). However, since previous studies have only identi®ed IFN as inducing these activities, we needed to determine whether these eects were due to IFN induction. To test this possibility, anti-human IFN antibodies were added to RA-treated HL-60 and WISH cells and 2'5'A synthetase activities were evaluated after 72 h for HL-60 and 24 h for WISH cells. Table 2 shows that anti-human IFNb antibodies had no eect on RA-induced 2'5'A synthetase activities in HL-60 and WISH cells, wherease anti-human IFNa antibodies abolished in part RA-induced enzyme activities, in both cell lines. This suggests that part of the RA eect could be due to the induction and subsequent secretion of IFNa. However, as the amounts of antibodies used in the experiment were amply sucient to neutralize 500 units/ml of IFN, the remaining 2'5'A synthetase activity suggest that RA can act independently of IFN secretion. The secreted IFN was tested by the ability of the culture medium of RA-treated HL-60 cells to induce 2'5'A synthetase and antiviral activities in bovine MDBK cells, in which these activities were highly induced by IFNa (ChelbiAlix and Thang, 1986) but not by RA (data not shown). It is clear from data shown in Figure 3 that culture medium from RA-treated HL-60 cells is able to induce 2'5'A synthetase activity in MDBK cells, and that this was completely abolished by the addition of anti-IFNa antibodies, demonstrating that IFNa is induced and secreted by RA-treated HL-60 cells. To estimate the amount of secreted IFN, the culture media, taken from RA-treated HL-60 cells, were titrated on MDBK or HeLa cells challenged with VSV ( Figure 3 and data not shown). IFN titers were expressed in relation to the human IFNa reference. The results show that RA caused the induction and secretion of 32 international units/ml of IFNa (at day 3) in HL-60 cells. Untreated HL-60 cells did not secrete detectable IFN activity (data not shown). It should be noted that we failed to detect IFN activity in the culture medium from RA-treated WISH cells. However, a very small amount of IFN would not have been detected by our assay (e.g. 54 units/ml).
Eect of RA, IFNa and their combination on antiproliferative and antiviral activities
Since the RA-treated HL-60 cells showed an increase in 2'5'A synthetase activity, PML, PKR and Sp100 proteins expression (Figure 1) , it was of interest to determine if RA could modulate the biological responses to IFNs (e.g. antiproliferative eect and antiviral state) in these cells. We studied the eect of combined treatment with RA (10 76 M for HL-60 and 10 75 M for WISH cells) and IFNa (100 units/ml). RA and IFNa inhibited the proliferation of HL-60 and WISH cells as indicated by a decreased number of viable cells (Figure 4 ). Treatment with IFNa and RA for 4 or 6 days increased the inhibitory eect of IFNa by 14 to 20% in both cell types (Figure 4) . In order to see whether the increase in the growth inhibition by RA was also accompanied by the establishment of an antiviral state, HL-60 cells were treated with RA or IFNa as control. After 3 days, cells were counted and 75 M RA (24 h) respectively in the presence or absence of anti-IFN a or b antibodies, the amounts of anti-IFN antibodies used were sucient to neutralize 500 units/ml of IFN and were added daily. 2'5' A synthetase activity was measured in cell extracts as described in Materials and methods an equal number of cells from each sample was infected with VSV at a multiplicity of 0.1. Immunouorescence analysis revealed that VSV antigens expression was inhibited in RA-as well as in IFNtreated HL-60 cells compared to control infected cells ( Figure 5 ). The titers of VSV in RA-or IFNa-treated cells were 150 and 1200 times lower respectively than in control infected cells. Next, we studied the eect of the combination of RA and IFNa on virus replication. HL-60 and WISH cells were treated, as described in Table 1 , with RA and/or IFNa for 24 h, and infected with VSV at a multiplicity of 0.1. Table 3 shows that the treatment of HL-60 and WISH cells with RA-IFNa combination aorded more antiviral protection against VSV infection than that with IFNa alone. RA boosted the antiviral activity by 40-fold in HL-60 cells and 11-fold in WISH cells.
The inhibition of VSV replication by RA in HL-60 and WISH cells might have been due to the induction of IFN by this compound. In order to test this possibility, we examined the eect of anti-IFNa antibodies on the antiviral state induced by RA in these cells. As a control, cells were treated with IFNa in the presence of anti-IFNa antibodies. Note that, upon RA treatment for 24 h, WISH cells did not secrete detectable IFN (data not shown) and HL-60 cells secreted only 4 units/ ml of IFNa (Figure 3) . The results, given in Table 3 , show that the presence of anti-IFNa antibodies had no eect on the inhibition of VSV replication induced by RA, whereas they completely abolished the action of IFNa. Thus, RA can inhibit VSV growth independently of IFN secretion.
Eect of RA, IFNa and their combination on the PML promoter
The results presented above show that the addition of RA enhanced the IFN-stimulated induction of several gene products. In part, this can be explained by IFN secretion upon RA treatment. In order to know whether this combination acts on promoters of the target genes, HepG2 cells were transfected with plasmids containing the luciferase reporter gene under the control of the entire PML promoter (pPromPML 1.44), and were treated for 24 h with RA (10 75 M) and IFNa (100 units/ml). In accordance to our previous results , the PML promoter responded to IFNa by a 2.5-fold increase of luciferase activity ( Figure 6a ) consistently with identi®cation of ISRE and GAS motifs. Interestingly, in the same conditions, RA alone caused a signi®cant increase of 1.6-fold. Moreover, combined treatment led to a much HL-60 and WISH cells were treated for 24 h with RA, as described in Table 1 , or IFNa (100 units/ml) in the presence or absence of antiIFNa antibodies, the amounts of anti-IFN antibodies used were sucient to neutralize 500 units/ml of IFN. HL-60 and WISH cells were also treated for 24 h by RA-IFNa combination. Cells were used for the determination of VSV growth as described in Materials and methods. Each value is the mean of three experiments, the dierence in the number of plaques counted at each dilution did not exceed 5%
higher augmentation of reporter activity (eightfold). Similar results were obtained by using RA 10 76 M (data not shown). Thus, RA modulation of IFNinducible gene expression occurs at the transcriptional level.
Eect of RA on IRF-1 promoter IRF-1 is a transcription factor that regulates the expression of IFN (Fujita et al., 1989) , and IFNinducible genes (Pine et al., 1990) . It has been recently shown that induction of IRF-1 gene expression in RAtreated NB4 cells was also observed in the absence of protein synthesis (Matikainen et al., 1996) , suggesting a direct activation of the gene. Moreover, in addition to the GAS regulatory motif (7114 to 7124) (Pine et al., 1994) , the IRF-1 gene promoter may also contain potential retinoic acid receptor element (from 7455 to 7440) (Matikainen et al., 1996) . To determine whether RA could act directly on the IRF-1 gene promoter through this site or through the GAS element, three constructions previously described (Pine et al., 1994) were used to transfect HepG2 cells: the IRF-1 upstream sequence (EcoRI ± PstI) linked to a luciferase reporter, the GAS element derived from IRF1 promoter driven luciferase reporter (WTGAS), and an analogous construct with a conservative GAS mutation (3MGAS) (Pine et al., 1994) . Transfected cells were treated for 24 h with RA (10 75 M), IFNa or IFNg (1000 units/ml) which were used as positive controls. Figure 6b shows the induction in response to RA, IFNa or IFNg. As reported before (Pine et al., 1994) , IFNg caused a tenfold induction with the entire (EcoRI ± PstI) or WTGAS constructions, while IFNa induction was about 2.5-fold. In the same conditions, RA caused an induction of 2.2-fold. Furthermore, WTGAS oligonucleotide responded to RA by a 2.1-fold increase, while the response of 3MGAS was reduced by 84% (Figure 6b) . Although, the eect of RA was modest, it was reproducible and observed in the presence of anti-IFNa antibodies (data not shown). Note that HepG2 cells did not secrete IFN upon RA treatment (data not shown).
Thus, the GAS (and not the putative RARE) was sucient to account for RA inducibility of IRF-1 gene. Moreover, RA-IFNa combination led to a higher augmentation of reporter activity with the entire or WTGAS constructions (Figure 6b ). These results indicated that RA could increase the expression of IFN-regulated genes through direct induction of IRF-1 independently of IFN secretion.
RA enhances the activation of STAT by IFNa and IFNg in HL-60 and WISH cells
STAT proteins are latent transcription factors activated by tyrosine phosphorylation in response to stimulation of several transmembrane spanning receptors (Schindler and Darnell, 1995) . They were originally identi®ed as part of the IFNs signaling system. It has been recently shown that RA increases the level of Stat1 in MCF-7, a breast tumor cell line resistant to growth inhibition by IFNb (Kolla et al., 1996) . To determine whether RA could modify biological responses in HL-60 and WISH cells through the STAT pathway, we studied the eect of RA on STAT activation and expression. First, we examined the ability of RA to aect the activation of these proteins by studying their DNA-binding activity to oligonucleotides in gel shift experiments. Since Stat1 is involved in both type I and type II IFN responses, a GAS element DNA-binding assay is sensitive to stimulation with either ligand. To take advantage of this assay, extracts were prepared from HL-60, WISH and HeLa cells and evaluated with a GAS probe. with the calcium-phosphate method. Twelve hours later medium was changed. Then cells were divided and treated for 24 h with RA (10 75 M), IFNa (100 units/ml) or both. (b) Eect of RA and IFNs on IRF-1 promoter. HepG2 cells were seeded on six dishes plate and transfected with 3 mg of pIRF-1 (EcoRI ± PstI), WTGAS and 3MGAS plasmids (Pine et al., 1994) with the calcium-phosphate protocol. Twelve hours later the medium was changed. Then cells were divided and treated with RA (10
IFNa or IFNg (1000 units/ml in each case). Luciferase activity was measured as described in Materials and methods. Each experiment included triplicate transfections for each construct. The data shown are the means and standard deviations of fold inductions 1994). The cells used in these studies were RApretreated for 24 h prior to stimulation with IFNa or IFNg for 15 min. As shown in Figure 7a , treatment with RA alone never led to the activation of STAT DNA-binding activity. However, RA pretreatment did signi®cantly augment STAT activation in response to IFNa and IFNg in HL-60 and WISH cells: for example, in HL-60 cells there was a 35% increase in Stat1 : 1 homodimer activation compared to IFNa (45% increase in Stat1 : 3 heterodimer), as quanti®ed by phosphorimager analysis. In RA-pretreated WISH cells, there was a 40% increase in Stat1 : 1 and a 89% in Stat3 : 3 homodimers compared to IFNa (61% in Stat1 : 3 heterodimer). In addition, these cells exhibited a 35% increase in Stat1 : 1 compared to IFNg. In contrast, RA pretreatment had no eect in increasing IFN responses in HeLa cells; it may even cause a small decrease (510%) in STAT DNA-binding activity (Figure 7a ). To verify if RA aects also Stat1 : 2 heterodimers, part of the ISGF3 complex, electrophoretic mobility shift assays (EMSA) were performed with an ISRE probe. RA pretreatment increased by 30% the DNA-binding activity of ISGF3 in WISH cells and had no eect on HeLa cells (data not shown). However, we failed to detect this same complex in HL-60 cells, as well as the endogeneous p48 protein (data not shown). In HL-60 cells, RA as well as IFNa seems to stimulate gene expression through the GAS element via activated STATs and/or the ISRE via IRF-1. Thus, in HL-60 and WISH cells, transcriptional activation by IFNa or IFNg was enhanced by RA at the level of trans-acting factor binding. Table 1 ) for 24 h, and then incubated with IFNa (100 units/ml) or IFNg (0.2 ng/ml) for 15 min. Nuclear extracts were prepared and assayed by EMSA with an IRF-1 GAS probe as previously described (Rothman et al., 1994) . Table 1 and, at the indicated times, cell extracts were used for Western blot as described in Materials and methods. The positions of STATs are indicated on the right
RA enhances STAT levels in HL-60 and WISH cells
Next, we determined whether the ability of RA to increase IFN-induced STAT activation might be attributed to changes in the level of expression of these proteins. Most cells have a constitutive level of STAT proteins (Darnell et al., 1994) . Extracts prepared from unstimulated or RA-stimulated HL-60, WISH and HeLa cells were examined by a sensitive STAT speci®c immunoblotting assay (Figure 7b ). These studies indicate that in HL-60 cells, RA increased the level of Stat1 dramatically after 4 days treatment, but only to a least extend increased Stat2 after 2 or 4 days and did not alter Stat3 levels. Note that on a longer exposure, endogeneous Stat1, Stat2 and Stat3 were clearly visible (data not shown). In WISH cells, Stat1 and Stat3 levels increased at day 2 and diminished at day 4, whereas Stat2 level were maximal at day 4. In HeLa cells, RA did not increase levels of any of these STATs, a small decrease could even be observed at day 4 ( Figure 7b ). In addition, RA at 24 h did not increase the level of expression of the 48 kDa component of the ISGF3 complex in any of these cell lines (data not shown). Taken together, these results suggest that the ability of RA to increase STAT protein expression in HL-60 and WISH cells could contribute to the observed potentiation of gene activation. These studies also suggest that the eect of RA on STAT expression may vary between cell lines.
Discussion
Several in vitro studies have demonstrated that a combined administration of RA and IFNs leads to a modulation in the expression of some IFN-induced genes (Ferbus et al., 1985; Lancillotti et al., 1995) and an increased inhibition of cell proliferation (Frey et al., 1991; Mangelsdorf et al., 1994) . However, the mechanisms by which RA and IFNs potentiate each other in their antiproliferative action remain to be elucidated, and are the focus of this study. We determined that several mechanisms are implicated: RA directly stimulates IRF-1 gene expression through its GAS motif and induces IFNa synthesis; RA also augments STAT levels and enhances IFN-induced STAT activation. We have shown that RA increased the expression of IFN-inducible proteins, such as 2'5'A synthetase, PKR, Sp100 and PML in HL-60 and WISH cells. Antihuman IFNa but not anti-IFNb antibodies inhibited the induction of 2'5'A synthetase activity by RA. However, this inhibition was not complete, suggesting that IFN-independent mechanisms may participate in the increase of IFN-inducible gene products by RA. The combination of RA and 100 units/ml of IFNa had a cooperative eect on these IFN-inducible proteins expression, in HL-60 and WISH cells. RA modulation of IFN-induced gene expression occurred at the transcriptional level as demonstrated by the capacity of RA to strongly enhance PML promoter stimulation by IFNa.
Interestingly, only HL-60 cells (Breitman et al., 1980) , but not WISH cells, dierentiate upon RA treatment; thus, the increased expression of IFN-inducible gene products by RA is not related to cell dierentiation.
Concurrently to the increase of the IFN-inducible proteins expression, RA inhibited VSV growth and cell proliferation. The antiviral and the growth inhibitory eects are potentiated by addition of IFN to both HL-60 and WISH cells. However, in these cells treated for 24 h by RA alone, inhibition of VSV replication is observed in the presence of anti-IFNa antibodies. Thus, RA can establish an antiviral state against VSV (this paper) and also, as previously shown, against EMCV (Bourgeade and Besancon, 1984) independently of IFN secretion. Our studies suggest that some of the cooperative eects could be explained in part by the synthesis and secretion of IFNa but that other mechanisms exist.
The transcription factor IRF-1 plays an important role in the expression of IFN and IFN-inducible genes (Lengyel, 1993) . This is achieved by binding the ISRE site (Pine et al., 1990) , mediating cytokine responses. Overexpression of IRF-1 leads to resistance to viral infection (Pine, 1992) . A recent study indicates that IRF-1 mRNA levels are elevated 1 h after RA treatment in HL-60 and NB4 cells, even in the absence of protein synthesis (Matikainen et al., 1996) suggesting that IRF-1 is a primary target gene for RA. In this report, we demonstrate that RA stimulates the IRF-1 gene expression with the same eciency as IFNa. In addition, the GAS motif, which mediates the induction of IRF-1 in response to IFNs, seems to be the major or unique RA responsive element in the IRF-1 promoter. Thus, RA-dependent upregulation of IRF-1 is apparently not mediated by the classical pathway involving nuclear retinoic acid receptor. Stat1 activation and/or induction caused by RA seems to be responsive for the increase in the transcriptional rate of IRF-1. These results are consistent with a model in which RA increased IRF-1 expression, which in turn promotes the expression of ISRE-driven genes like PML , Sp100 (GroÈ tzinger et al., 1996) , PKR (Tanaka and Samuel, 1994) and 2'5'A synthetase (Rutherford et al., 1988) .
The synergistic eects between RA and IFN on both the induction of genes and more general responses is likely to be achieved by several complementary mechanisms. First, in some cells, RA increased the levels of STAT protein expression after 2 days. However, the nature of the STAT and the level of increase vary substantially between cells. Thus, RA augmentation of STAT may be a crucial step in the enhancement by RA of biological responsiveness to IFNs. The Stat1 gene seems to be a direct target gene for RA since in HL-60 cells, induction of Stat1 mRNA by RA was observed in the presence of cycloheximide (data not shown). Moreover, very recently, Weihua et al. show that the promoter of Stat1 directly respond to RA treatment. Second, STATs can be activated directly by RA in NB4 cells (Gianni' et al., 1997) . However, RA alone failed to induce STATs activation in MCF-7, HL-60 or WISH cells (Kolla et al., 1996 and this paper) . Our data suggest that RA stimulates the production of IFN which in turn activates STAT proteins in HL-60 cells. Third, the synergy observed between RA and IFN during short treatment protocols suggest a more rapid mechanism. Since RA does not alter the expression or the activation of Jak1, Jak2 or Tyk2 proteins in NB4 cells (Gianni' et al., 1997) , it may enhance STAT activity through, for instance, the activation of MAP kinases, which have been shown to modulate STAT activation (Wen et al., 1995) . Studies are in progress to elucidate whether phosphorylation of Stat1 is implicated in this phenomenon.
Taken together, these results lead us to propose a model for activation of IFN-stimulated genes by RA (Figure 8) . One of the primary events of RA could be the induction of IRF-1 gene expression through the GAS motif and activated STATs. De novo synthesised IRF-1 activates directly a variety of IFN-inducible genes and the IFNa gene itself, leading to a positive feedback on IRF-1 expression. On long-term, RA also increases STAT levels, which could be activated by the RA-induced IFNa. Moreover, exogeneous IFN could enhance, on short-term or long-term, the activation of STAT.
Materials and methods

Reagents
Adenosine 5'[a 32 P]triphosphate (410 Ci/mmol) was purchased from Amersham, Polyriboinosinic-polyribocytidylic acid (Poly(I)-poly(C)) was from Pharmacia and all-trans-retinoic acid (RA) from Sigma. DMEM, RPMI and fetal bovine serum were supplied by Gibco, France.
Cell culture
Cells were grown at 378C: HL-60 human promyelocytic leukemia cells in RPMI medium, bovine MDBK, human WISH, HeLa and HepG2 cells and mouse L929 cells, in DMEM supplemented with 10% heat inactivated fetal calf serum.
Human IFNs and anti-human IFN antibodies
Recombinant IFNa2 (10 8 international units/mg) was from Schering (USA). Anti-human IFNa (G-030-501-553) and IFNb (G-028-501-568) antibodies, having 7.5 10 5 and 1.2 10 4 neutralizing units/ml respectively, were obtained from the National Institute of Health.
Determination of IFN titers
RA-induced IFN was titrated on MDBK and HeLa cells challenged with vesicular stomatitis virus (VSV). IFN titers, determined as the amounts of IFN required to produce 50% inhibition of the cytopathic eect, were expressed in relation to the human IFNa reference (G-023-902-527, National Institute of Health).
Assay of VSV yield
VSV was grown in the L929 cells. Treated cells were counted and infected with VSV at a multiplicity of infection of 0.1. After 18 h, cultures were frozen, thawed three times and cell debris removed by centrifugation. The supernatants were serially diluted and virus titers were measured by a plaque assay in L929 cells, and expressed as plaque-forming units/ml (PFU/ml). VSV yield in control cultures was usually 10 8 PFU/ml. The antiviral activity of IFN or any other compound tested was measured by reduction in the virus yield.
Assay of 2'5'A synthetase
After treatment, cells were washed with buer A (140 mM NaCl, 3 mM MgCl 2 , 35 mM HEPES pH 7.5) and then lysed for 5 min at 08C in buer B (0.5% NP-40, 5 mM MgAc, 1 mM DTT, 25 mM KCl, 10% glycerol, 20 mM Tris-HCl pH 8). Cell lysates were pelleted for 6 min in an Eppendorf centrifuge and the cell extracts were stored at 7808C until assayed. For the 2'5'A synthetase assay, 100 ml of each cell extract were tested as described (Justesen et al., 1980) . One unit of 2'5'A synthetase activity corresponds to 1 nmol ATP converted/h at 378C and its speci®c activity is expressed as units/mg of protein in the cell extract.
Immuno¯uorescence and Western blot analysis
Cells were ®xed in 4% paraformaldehyde for 10 min at 48C, followed by 5 min in 100% methanol at 48C. Immuno¯uorescence was performed with monoclonal anti-PML (1/100), rabbit anti-Sp100 (1/400) or anti-VSV (1/2000) antibodies and revealed with FITC or Texas red conjugated secondary antibodies.
For Western blot analysis, cells were scraped in PBS, centrifuged and pellet was resuspended in lysis buer (125 mM Tris pH 7, 1% SDS, 10% glycerol, 0.75 mM PMSF). Each sample was sonicated to reduce viscosity. Western blot analysis was performed according to standard procedures (Harlow and Lane, 1988) . Twenty micrograms of whole cell extract were analysed using rabbit anti-PML (1/2000), antiSp100 (1/400) or monoclonal anti-PKR (1/5000) (from RiboGene, Hayward, CA) antibodies and revealed by chemoluminescence (ECL, Amersham). The polyclonal anticarboxy terminal Stat1 and Stat2 antibodies were used as described (Gupta et al., 1996) . Stat3 (C20) was purchased from Santa Cruz. Rabbit anti-actin antibodies were from Sigma.
DNA constructions
The pPromPML1.44-Luc plasmid was described elsewhere . Brie¯y, a genomic 1.44 kb fragment, containing the 5' region upstream of the ®rst ATG of PML gene, was subcloned in the Bluescript II SK + phagemid according to standard procedures (Ausubel et al., 1994) . A full-length, intronless luciferase construct, LD5 ' (de Wet et al., 1987) was then introduced at a downstream NcoI site to generate above mentioned construction. The IRF-1 promoter containing plasmid was previously described (Pine et al., 1994) . EcoRI ± PstI fragment which contains the entire IRF-1 promoter was subcloned into a HindIII site of the pZluc promoterless luciferase reporter vector. WTGAS is an oligonucleotide spanning the IRF-1 GAS and 3MGAS is a IRF-1 GAS mutant obtained by ligation of a synthetized oligonucleotide containing the AA to CC Figure 8 A model for activation of IFN-stimulated genes by RA mutation at positions 7115 and 7116 into the HindIII site of ptkLuc as described in (Pine et al., 1994) .
Transient transfection
HepG2 cells (10 5 /ml) were seeded in six dishes plates and transfected with 3 mg of plasmid DNA using the calcium phosphate method as described previously . To avoid dierences in transfection eciency, the transfected cells were split. One half was treated as described in the Figure 6 legend, the other half served as control. Twenty hours later, cells were harvested and relative luciferase units were measured with a luminometer.
Electrophoretic mobility shift assays
When HeLa or WISH cells reached 70% con¯uency or in the case of HL-60 cells 5610 5 to 1610 6 cells/ml, RA was added for 24 h to a ®nal concentration of 10 76 M (HL-60 cells) or 10 75 M for WISH and HeLa cells. Then the RA treated or untreated cells were stimulated with IFNa (100 units/ml) or IFNg (0.2 ng/ml) for 15 min. Cells were harvested and washed with cold PBS, and nuclear extracts prepared (Gupta et al., 1996) . Each of the extracts was examined by EMSA with either a GAS from the IRF-1 gene (gatcGATTTCCCCGAAAT) or an ISRE probe from the ISG15 gene promoter (gatcTTTCACTTTCTAGTTT-CACTTT CCCTTT) as described (Gupta et al., 1996) . After autoradiography the shift bands were quanti®ed with a Biorad GS250 phosphorimager.
